Abstract
We employed human SK-MEL-28 cells as a model system to identify cellular proteins that accompanyN-(4-methyl)phenyl-O-(4-methoxy)phenyl-thionocarbamate (MMTC)-induced apoptosis based on a proteomic approach. Cell viability tests revealed that SK-MEL-28 skin cancer cells underwent more cell death than normal HaCaT cells in, a dose-dependent manner after treatment with MMTC. Two-dimensional electrophoresis in conjunction with matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry analysis or computer matching with a protein database further revealed that the MMTC-induced apoptosis is accompanied by increased levels of caspase-1, checkpoint suppressor-1, caspase-4, NF-κB inhibitor, AP-2, c-Jun-N-terminal kinase, melanoma inhibitor, granzyme K, G1/S specific cyclin D3, cystein rich protein, Ras-related protein Rab-37 or Ras-related protein Rab-13, and reduced levels of EMS (oncogene), ATP synthase, tyrosine-phosphatase, Cdc25c, 14-3-3 protein or specific structure of nuclear receptor. The migration suppressing effect of MMTC on SK-MEL-28 cell was tested. MMTC suppressed the metastasis of SK-MEL-8 cells. It was also identified that MMTC had little angiogenic effect because it did not suppress the proliferation of HUVEC cell line. These results suggest that MMTC is a novel chemotherapeutic and metastatic agents against the SK-MEL-28 human melanoma cell line.
Similar content being viewed by others
References
Ashkenazi, A., Death receptor: Signaling and modulation.Science, 281, 1322–1326 (1998).
Berke, G., The CTL's kiss of death,Cell, 81, 9–12 (1995).
Berke, G., Unlocking the secrets of CTL and NK cells.Immunol. Today., 16, 343–346 (1995).
Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D., Involvement of MACH, a novel MORT1/FADD interacting protease, in Fas/APO-1 and TNFReceptor-induced cell death.Cell, 85, 803–815 (1996).
Casano, F. J., Rolando, A. M., Mudgett, J. S., and Molineaux, S. M., The structure and complete nucleotide sequence of the murine gene encoding interlekin-1β converting enzyme (ICE).Genomics, 20, 474–481 (1994).
Cen, D., Gonzalez, R. I., Buckmeier, J. A., Kahlon, R. S., Tohidian, N. B., and Meyskens, F. L., Jr., Disulfiram induces apoptosis human melanoma cell via redox-related process,Mol. Cancer Ther., 1, 197–204 (2002).
Chen, C. Y. and Faller, D. V., Direction of p21 ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2.Oncogene, 11, 1487–1698 (1995).
Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M., FADD, a novel death domain-containing protein, interacts with the death domain of Das and initiates apoptosis.Cell, 81, 505–512 (1995).
Elledge, S. J., Cell cycle checkpoints: Preventing an identity crisis.Science, 274, 1664–1667 (1996).
Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., and Johnson, E. M., Altered gene expression in neurons during programmed cell death: identification of c-JUN as necessary for neuronal apoptosis.J. Cell Biol., 127, 1717–1727 (1994).
Fidler, I. J., Schackert, G., Zhang, R. D., Radinsky, R., and Fujimaki, T.,Cancer and Metastasis Reviews, 18, 387–400 (1999).
Folkman, J. and Shing, Y., Angiogenesis.J. Biol. Chem., 267, 10931–10934 (1992).
Ham, J., Babij, C., Whitfield, J., Pfarrc, M., Lallemand, D., Yamiv, M., and Rubin, L., A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death.Neuron, 14, 927–939 (1995).
Hanabuchi, S., Koyanagi, M., Yonehara, S., Yagita, H., and Okumura, K., Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity.Proc. Natl. Acad. Sci., USA., 91, 4930–4934 (1994).
Hanahan, D. and Weinberg, R. A., The hall-mark of cancer,Cell, 100, 57–70 (2000).
Henkart, P. A., Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector.Immunity, 1, 343–346 (1994).
Henkart, P. A., ICE-family proteases: Mediators of all apoptotic cell death?Immunity, 4, 195–201 (1996).
Hofmann, K., Bucher, P., and Tschopp, J., The CARD domain: a new apoptotic signaling motif.Trends Biochem. Sci., 22, 155–156 (1997)
Kamens, J., Paskind, M., Hugunin, M., Talanian, R. V., Allen, H., Banach, D., Bump, N., Hackett, M., Johnston, C. G., Li, P., Mankovich, J. A., Terranova, M., and Ghayur, T., Identification and characterization of ICH-2, a novel member of the interleukin-1β-converting enzyme family of cystein proteases.J. Biol. Chem., 270, 15250–15256 (1995).
Kauffmann-Zeh, A., Rodriguez-Viciana, E., Ulrich, P., Gilbert, C., Coffer, P., Downward, J., and Evan, G., Suppression of c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB.Nature, 385, 544–548 (1997).
Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G., Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.Cancer Res., 53, 3976–3985 (1993).
Liu, G. Y., Frank, N., Bartsch, H., and Lin, J. K., Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NF-kappa B,c-fos/c-jun, and p53 proteins.Mol. Carcinog., 22, 235–246 (1998).
Menashe, B. E., Role of AP-2 in tumor growth and metastasis of human melanoma.Cancer and Metastasis Reviews, 18, 377–385 (1999).
Mesner, P. W., Epiting, C. L., Megarty, J. L., and Green, S. H., A time table of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells.J. Neurosci., 15, 7357–7366 (1995).
Moellering, D., McAndrew, J., Jo, Ho., and Darley-Usmar, V. M., Effect of pyrolidine dithiocarbamate on endothelial cells: Protection against oxidative stress.Free Radical Biol. Med., 26, 1138–1145 (1999).
Morton, D. L. and Barth, A., Vaccine therapy for malignant melanoma. CA.Cancer J. Clin., 46, 225–244 (1996).
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, K. H., Peter, M. E., and Dixit, V. M., FLICE, a novel FADD-Homologous ICE/CED-3 like protease is recruited to the CD95 (Fas/APO-1) death inducing-signaling complex.Cell, 85, 817–827 (1996).
Qu, C. K., Role of the SHP-2-tyrosine phosphatase in cytokine-induced signaling and cellular response.Biochim. Biophys. Acta., 1592, 297–301 (2002).
Rodriguez-Vicente, J., Vicente-Ortega, V., and Canteras-Jordana, M., Effects of different antineoplastic agents and a pretreatment by modulators n three melanoma lines.Cancer, 82, 495–502 (1988).
Rudolfo, M., Daniotti, M., and Vallacchi, V., Genetic progression of metastatic melanoma. Cancer Lett., 214, 133–147 (2004).
Satyamoorthy, K., Meler, F., Ksu, M. Y., Berking, C., and Herhyn, M., Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression.Cancer and Metastasis Reviews, 18, 401–405 (1995).
Schadendorf, D., Worm, M., Algermissen, B., Kohlmus, C. M., and Czarnetzki, B. M., Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical reponse and in vitro drug sensitivity.Cancer, 73, 103–108 (1994).
Shi, L., Kam, C. M., Powers, J. C., Aebersold, R., and Greenberg, A. H., Purification of three cytotoxic lymphocyte granule serine proteases that inducd apoptosis through distinct substrate and target cell interactions.J. Exp. Med., 176, 1521–1529 (1992).
Shi, L., Kraut, R. P., Aerersold, R., and Greenberg, A. H., A natural killer cell granule protein that induces DNA fragmentation and apoptosis.J. Exp. Med., 175, 553–566 (1992).
Singh, A. K., Seth, P., Anthony, P., Husain, M. M., Madhavan, S., Mukhtar, H., and Maheshwari, R. K., Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.Archives of Biochemistry and Biophysics, 401, 29–37 (2002).
Smyth, M. J. and Trapani, J. A., Granzymes: exogenous porteinases that induce target cell apoptosis.Immunol. Today, 16, 202–206 (1995).
Suda, T., Takahashi, T., Golstein, P., and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the Tumor Necrosis Factor family.Cell, 75, 1169–1178 (1993).
Sung, N. D., Myung, P. K., Seong, M. G., Yu, S. J., and Choi, S. L., QSAR anlyses on the cell cytotoxicity of someN-phenyl-O-phenylthionocarbamate derivatives using Comparative Molecular Field Analysis (CoMFA) based on different alignment approaches and Holographic Quantitative Structure-Activity Relationship (QSAR),Agri. Chem. Biotechnol., 46, 137–143 (2003).
Sung, N. D. and Soung, M. K., Phenyl substituents effect on the fungicidal activity ofN-phenyl-O-phenylthiono carbamate derivatives.Kor. J. Pestic. Sci., 3, 29–36 (1999).
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.Cell, 76, 969–976 (1994).
Takakura, K., Sano, K., Hojo, S., and Hirano, A., Metastatic tumors of the central nervous system.Igaku- shoin Ltd. Tokyo, Japan, (1982).
Tewari, M., Telford, W. G., Miller, R. A., and Dixit, V. M., Crm A, a poxvirus-encoded serpin, Inhibits cytotoxic T-lymphocyte-mediated apoptosis.J. Biol. Chem., 270, 22705–22708 (1995).
Tom, J. and Dafna, B. S., Suppression of Ras-induced apoptosis by the RacGTPase.Mol. Cell Biol., 19, 5892–5901 (1999).
Toru, T., Akio, S., and John, D. M., The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation.J. Biol. Chem., 275, 14248–14254 (2000).
Trede, N. S., Tsytsykova, A. V., Chatila, T., Goldfeld, A. E., and Geha, R. S., Transcriptional activation of the human TNF-alpha promoter by super antigen in human monocytic cells: role of NF-kappa B.J. Immunol., 155, 902–908 (1995).
Wheeler, M. A., Townsend, M. K., Yunker, L. A., and Mauro, L. J., Transcriptional activation of the tyrosine phosphatase gene, OST-PTP during osteoblast differentiation.J. Cell. Biochem., 87, 363–376 (2002).
Wu, H. and Lozano, G., NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress.J. Biol. Chem., 269, 20067–20074 (1994).
Xia, Z., Dickens, M., Rainge, J., Davis, R. J., and Greenberg, M. E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.Science, 270, 1326–1331 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Choi, SL., Choi, YS., Kim, YK. et al. Proteomic analysis and the antimetastatic effect ofN-(4-methyl)phenyl-O-(4-methoxy) phenyl-thionocarbamate-induced apoptosis in human melanoma SK-MEL-28 cells. Arch Pharm Res 29, 224–234 (2006). https://doi.org/10.1007/BF02969398
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02969398